Sign in
Taking people in United StatesNo phase

Collecting urine samples to help develop the Bladder EpiCheck bladder cancer test

Collects urine from adults suspected of bladder cancer or under monitoring for it.

Key facts

Who runs it
Nucleix Ltd.
Where
San Diego and Towson, United StatesSee the 2 sites
Trial code
Registry title
Bladder EpiCheck Product Development Study
Status
Recruiting
People taking part
1,000 people, planned
Started
15 Sept 2025
Expected to end
Dec 2026
Type of study
Observational, 3 groups
Treatments tested
  • Bladder EpiCheck
Record updated
7 April 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults aged 22 or older who are planned to have a bladder procedure for a suspected bladder tumor or for NMIBC surveillance. They give one urine sample during a single visit.

Age
22 years or older
Sex
All sexes can join.
Disease stage
Suspected or detected bladder tumor, or non-muscle invasive bladder cancer (NMIBC) under surveillance. People with known or past muscle invasive bladder cancer cannot join.
Earlier treatment
No treatment for prostate cancer or kidney cancer (RCC) in the past 2 years.

Main reasons for not taking part

  • Known or past muscle invasive bladder cancer (MIBC)
  • Treatment of prostate cancer or RCC in the past 2 years
  • Already enrolled in this study within the prior 60 days

The registry criteria, word for word

Show all 6 criteriaShow less

Who can take part

  • Age 22 or older
  • Willing and able to sign the informed consent form
  • Subject(s) that is planned to undergo ,within 60 days, one of the following procedures:; 3.1 TURBT due to suspected or detected bladder tumor, or 3.2 Cystoscopy under general anesthesia due to suspected bladder tumor, or 3.3 Cystoscopy for NMIBC surveillance

Who cannot take part

  • Patients previously enrolled into this study within the prior 60 days
  • Patients with known or history of muscle invasive bladder cancer (MIBC)
  • Treatment of prostate cancer or RCC in the past 2 years

Where in United States

  • Om Research LLCSan Diego, United StatesContact: GavriushinaTaking people
  • Chesapeake Urology Research AssociatesTowson, United StatesContact: PhelpsTaking people

About the trial

What the trial wants to find out

This is a prospective, observational study to support the development of the Bladder EpiCheck kit by collecting urine samples from subjects suspected to have a bladder tumor or under NMIBC surveillance.

Read full original descriptionShow less

This is a single visit study. Each subject will sign the informed consent and provide voided urine sample. Demography and, if performed, pathology information will be collected for each subject.

The 3 groups in the trial

  • Subjects planned to undergo TURBT due to suspected or detected bladder tumor

    Adult subjects planned to undergo TURBT within 60 days due to suspected or detected bladder tumor (e.g., by cystoscopy, cytology, imaging) will be enrolled. Voided urine will be collected prior to the procedure and sent to a central lab to perform blinded Bladder EpiCheck testing.

    Treatment: Bladder EpiCheck

  • Subjects planned to undergo cystoscopy under general anesthesia due to suspected bladder tumor

    Adult subjects planned to undergo cystoscopy under general anesthesia ,within 60 days due to suspected bladder tumor will be enrolled. Voided urine will be collected prior to the procedure and sent to a central lab to perform blinded Bladder EpiCheck testing.

    Treatment: Bladder EpiCheck

  • Subjects planned to undergo cystoscopy for NMIBC surveillance

    Adult subjects planned to undergo cystoscopy for NMIBC surveillance ,within 60 days will be enrolled. Voided urine will be collected prior to the procedure and sent to a central lab to perform blinded Bladder EpiCheck testing.

    Treatment: Bladder EpiCheck

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Collection of Urine Samples to Support the Bladder EpiCheck Product Development Studies
Plain-language title
Collecting urine samples to help develop the Bladder EpiCheck bladder cancer testGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Record updated
7 April 2026